REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea
· Delayed Price · Currency is KRW 10,150
-300 (-2.87%)
At close: Mar 9, 2026
REYON Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 186,161 | 235,498 | 303,360 | 384,347 | 631,111 | 390,433 | Upgrade
|
| Market Cap Growth | -22.46% | -22.37% | -21.07% | -39.10% | 61.64% | 47.64% | Upgrade
|
| Enterprise Value | 391,861 | 381,553 | 498,164 | 550,681 | 726,725 | 401,156 | Upgrade
|
| Last Close Price | 10150.00 | 12840.00 | 16540.00 | 21444.72 | 34972.84 | 21582.97 | Upgrade
|
| PE Ratio | - | 56.73 | 84.66 | 52.23 | 116.61 | 101.56 | Upgrade
|
| PS Ratio | 1.25 | 1.59 | 2.01 | 2.50 | 4.42 | 3.00 | Upgrade
|
| PB Ratio | 0.80 | 0.94 | 1.22 | 1.55 | 2.57 | 1.70 | Upgrade
|
| P/TBV Ratio | 0.80 | 0.95 | 1.23 | 1.56 | 2.59 | 1.71 | Upgrade
|
| P/OCF Ratio | - | - | 35.09 | 44.03 | 54.01 | 84.89 | Upgrade
|
| EV/Sales Ratio | 2.62 | 2.57 | 3.30 | 3.58 | 5.09 | 3.09 | Upgrade
|
| EV/EBITDA Ratio | - | 71.21 | 76.00 | 61.31 | 117.02 | 64.51 | Upgrade
|
| EV/EBIT Ratio | - | - | 281.00 | 123.81 | 470.45 | 242.53 | Upgrade
|
| EV/FCF Ratio | -41.46 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.92 | 0.82 | 0.91 | 0.85 | 0.85 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 181.50 | 38.08 | 34.33 | 23.40 | 33.38 | 9.56 | Upgrade
|
| Net Debt / Equity Ratio | 0.88 | 0.78 | 0.81 | 0.70 | 0.45 | 0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | 174.25 | 36.18 | 30.64 | 19.39 | 17.69 | 2.25 | Upgrade
|
| Net Debt / FCF Ratio | -21.76 | -11.11 | -9.93 | -3.20 | -1.04 | -0.29 | Upgrade
|
| Asset Turnover | 0.31 | 0.30 | 0.31 | 0.32 | 0.36 | 0.44 | Upgrade
|
| Inventory Turnover | 2.79 | 1.99 | 2.25 | 2.60 | 2.35 | 2.22 | Upgrade
|
| Quick Ratio | 0.34 | 0.35 | 0.51 | 1.63 | 2.91 | 1.83 | Upgrade
|
| Current Ratio | 0.60 | 0.66 | 0.80 | 2.27 | 3.47 | 2.42 | Upgrade
|
| Return on Equity (ROE) | -5.93% | 1.67% | 1.44% | 3.02% | 2.33% | 1.70% | Upgrade
|
| Return on Assets (ROA) | -3.35% | -0.12% | 0.22% | 0.58% | 0.24% | 0.35% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.92% | -0.18% | 0.36% | 1.15% | 0.49% | 0.66% | Upgrade
|
| Return on Capital Employed (ROCE) | -7.70% | -0.30% | 0.50% | 1.00% | 0.40% | 0.60% | Upgrade
|
| Earnings Yield | -7.65% | 1.76% | 1.18% | 1.93% | 0.88% | 0.98% | Upgrade
|
| FCF Yield | -5.08% | -7.41% | -6.67% | -14.16% | -16.68% | -12.22% | Upgrade
|
| Dividend Yield | - | - | 0.91% | 0.70% | 0.71% | 0.93% | Upgrade
|
| Payout Ratio | - | 66.27% | 76.41% | 61.38% | 62.56% | 150.47% | Upgrade
|
| Buyback Yield / Dilution | -0.83% | - | -0.46% | -3.03% | -4.05% | -1.01% | Upgrade
|
| Total Shareholder Return | -0.83% | - | 0.45% | -2.33% | -3.34% | -0.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.